Identification and Characterization of Four Azole-Resistant erg3 Mutants of Candida albicans
- 1 November 2010
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (11), 4527-4533
- https://doi.org/10.1128/aac.00348-10
Abstract
Sterol analysis identified four Candida albicans erg3 mutants in which ergosta 7,22-dienol, indicative of perturbations in sterol Δ 5,6 -desaturase (Erg3p) activity, comprised >5% of the total sterol fraction. The erg3 mutants (CA12, CA488, CA490, and CA1008) were all resistant to fluconazole, voriconazole, itraconazole, ketoconazole, and clotrimazole under standard CLSI assay conditions (MIC values, ≥256, 16, 16, 8, and 1 μg ml −1 , respectively). Importantly, CA12 and CA1008 retained an azole-resistant phenotype even when assayed in the presence of FK506, a multidrug efflux inhibitor. Conversely, CA488, CA490, and three comparator isolates (CA6, CA14, and CA177, in which ergosterol comprised >80% of the total sterol fraction and ergosta 7,22-dienol was undetectable) all displayed azole-sensitive phenotypes under efflux-inhibited assay conditions. Owing to their ergosterol content, CA6, CA14, and CA177 were highly sensitive to amphotericin B (MIC values, −1 ); CA1008, in which ergosterol comprised −1 ). CA1008 harbored multiple amino acid substitutions in Erg3p but only a single conserved polymorphism (E266D) in sterol 14α-demethylase (Erg11p). CA12 harbored one substitution (W332R) in Erg3p and no residue changes in Erg11p. CA488 and CA490 were found to harbor multiple residue changes in both Erg3p and Erg11p. The results suggest that missense mutations in ERG3 might arise in C. albicans more frequently than currently supposed and that the clinical significance of erg3 mutants, including those in which additional mechanisms also contribute to resistance, should not be discounted.Keywords
This publication has 40 references indexed in Scilit:
- A Clinical Isolate of Candida albicans with Mutations in ERG11 (Encoding Sterol 14α-Demethylase) and ERG5 (Encoding C22 Desaturase) Is Cross Resistant to Azoles and Amphotericin BAntimicrobial Agents and Chemotherapy, 2010
- Fluconazole Modulates Membrane Rigidity, Heterogeneity, and Water Penetration into the Plasma Membrane in Saccharomyces cerevisiaeBiochemistry, 2009
- Functional Interactions between Sphingolipids and Sterols in Biological Membranes Regulating Cell PhysiologyMolecular Biology of the Cell, 2009
- Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug ResistanceEukaryotic Cell, 2008
- Evaluation of Amphotericin B Interpretive Breakpoints for Candida Bloodstream Isolates by Correlation with Therapeutic OutcomeAntimicrobial Agents and Chemotherapy, 2006
- Fluconazole Treatment Is Effective against a Candida albicans erg3/erg3 Mutant In Vivo Despite In Vitro ResistanceAntimicrobial Agents and Chemotherapy, 2006
- Y132H substitution inCandida albicanssterol 14α-demethylase confers fluconazole resistance by preventing binding to haemFEMS Microbiology Letters, 1999
- The G464S Amino Acid Substitution in Candida albicans Sterol 14α-Demethylase Causes Fluconazole Resistance in the Clinic through Reduced AffinityBiochemical and Biophysical Research Communications, 1999
- Modeling cytochrome P450 14α demethylase (Candida albicans) from P450camJournal of Molecular Graphics, 1994
- Defective sterol C5-6 desaturation and azole resistance: A new hypothesis for the mode of action of azole antifungalsBiochemical and Biophysical Research Communications, 1989